Compound | VSS | Detection in Rat Brain | fu | Membrane Permeability, Caco-2 Cell-based Papp (EfR) | B/P Ratio | |||
---|---|---|---|---|---|---|---|---|
Human | Rat | Human (%) | Rat (%) | Human | Rat | |||
l/kg | ||||||||
Senkyunolide I (15) | 1.18 ± 0.17 | 2.19 ± 0.11 | Detected; KP, 1.8 | 53.6 | 48.3 | Good, 39.0 × 10−6 (1.2) | 0.69 | 0.82 |
Senkyunolide G (12) | 0.09 ± 0.01 | 0.85 ± 0.10 | Not detected | 3.0 | 13.3 | Good, 27.8 × 10−6 (1.4) | 0.62 | 0.61 |
Senkyunolide H (16) | 1.19 ± 0.12 | 2.02 ± 0.06 | Detected; KP, 1.0 | 49.8 | 48.1 | Good, 34.7 × 10−6 (1.3) | NM | 0.78 |
Senkyunolide N (17) | 0.98 ± 0.26 | 1.18 ± 0.07 | Detected; KP, 1.4 | 76.0 | 74.6 | Good, 17.3 × 10−6 (1.4) | NM | 0.90 |
3-Hydroxy-3-n-butylphthalide (10) | 0.22 ± 0.04 | 0.64 ± 0.12 | Not detected | 17.9 | 18.1 | Good, 3.62 × 10−6 (2.4) | NM | 0.74 |
B/P ratio, blood-to-plasma concentration ratio; EfR, efflux ratio; fu, unbound fraction of compound in plasma; KP, AUC-based partition coefficient of compound between brain and plasma; NM, not measured.